Loading…
Reported covered position: Legislative Intern, Representative Dean Phillips (D-MN-03), September 2019-December 2019
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Source: Senate LDA
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Access to Genetic Counselor Services Act of 2025
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Access to Genetic Counselor Services Act of 2026
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
SAFE Drugs Act of 2026
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
SAFE Drugs Act of 2026
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
SAFE Drugs Act of 2026
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Access to Genetic Counselor Services Act of 2025
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Protecting Patients from Deceptive Drug Ads Act
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Protecting Patients from Deceptive Drug Ads Act
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Protecting Patients from Deceptive Drug Ads Act
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Protecting Patients from Deceptive Drug Ads Act
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Protecting Patients from Deceptive Drug Ads Act
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Protecting Patients from Deceptive Drug Ads Act
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Protecting Patients from Deceptive Drug Ads Act
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Protecting Patients from Deceptive Drug Ads Act
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Access to Genetic Counselor Services Act of 2023
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
Access to Genetic Counselor Services Act of 2023
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R.3876/ S.2323 - Access to Genetic Counselor Services Act of 2023
Access to Genetic Counselor Services Act of 2023
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
Access to Genetic Counselor Services Act of 2023
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R.3876/ S.2323 - Access to Genetic Counselor Services Act of 2023
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Seniors’ Access to Critical Medications Act of 2024
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
Seniors’ Access to Critical Medications Act of 2024
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
Protecting American Seniors’ Access to Care Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
Protecting American Seniors’ Access to Care Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
Protecting American Seniors’ Access to Care Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Protecting American Seniors’ Access to Care Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
BUPE for Recovery Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
BUPE for Recovery Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
Access to Genetic Counselor Services Act of 2023
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R.3876/ S.2323 - Access to Genetic Counselor Services Act of 2023
Access to Genetic Counselor Services Act of 2023
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
Access to Genetic Counselor Services Act of 2023
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R.3876/ S.2323 - Access to Genetic Counselor Services Act of 2023
Access to Genetic Counselor Services Act of 2023
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
BUPE for Recovery Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
BUPE for Recovery Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Support for Patients and Communities Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Block, Report, and Suspend Suspicious Shipments Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Access to Genetic Counselor Services Act, H.R. 6280; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Access to Genetic Counselor Services Act; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · 2A
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · 2A
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · 1A
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Access to Genetic Counselor Services Act; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Access to Genetic Counselor Services Act; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NE HEALTHCARE SERVICES, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Congressionally Directed Spending request; Federal funding for employment training and other services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · 4A
H.R.3876/ S.2323 - Access to Genetic Counselor Services Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
H.R.3876/ S.2323 - Access to Genetic Counselor Services Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · RR
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · RR
Research funding and therapy development.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE